0.00
price down icon100.00%   -59.98
after-market Handel nachbörslich: 60.01 60.01 +
loading
Schlusskurs vom Vortag:
$59.98
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$2.34B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-76.34M
KGV:
0.00
EPS:
-2.5513
Netto-Cashflow:
$-65.93M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
Value
$0.00
$0.00
1-Wochen-Bereich:
Value
$0.00
$0.00
52-Wochen-Spanne:
Value
$0.00
$60.03

Longboard Pharmaceuticals Inc Stock (LBPH) Company Profile

Name
Firmenname
Longboard Pharmaceuticals Inc
Name
Telefon
619-592-9775
Name
Adresse
4275 EXECUTIVE SQUARE, LA JOLLA
Name
Mitarbeiter
33
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
LBPH's Discussions on Twitter

Vergleichen Sie LBPH mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
LBPH
Longboard Pharmaceuticals Inc
0.00 2.34B 0 -76.34M -65.93M -2.23
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
405.27 104.37B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
715.13 78.59B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
628.32 37.57B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
242.26 31.25B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.51 27.21B 3.30B -501.07M 1.03B -2.1146

Longboard Pharmaceuticals Inc Stock (LBPH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-09-10 Eingeleitet Truist Buy
2024-07-01 Bestätigt Cantor Fitzgerald Overweight
2024-05-01 Eingeleitet Robert W. Baird Outperform
2024-02-16 Eingeleitet Citigroup Buy
2023-10-24 Fortgesetzt Cantor Fitzgerald Overweight
2023-04-27 Eingeleitet B. Riley Securities Buy
2021-04-07 Eingeleitet Evercore ISI Outperform
2021-04-06 Eingeleitet Cantor Fitzgerald Overweight
2021-04-06 Eingeleitet Citigroup Buy
2021-04-06 Eingeleitet Guggenheim Buy
Alle ansehen

Longboard Pharmaceuticals Inc Aktie (LBPH) Neueste Nachrichten

pulisher
Dec 22, 2024

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Shares Acquired by State Street Corp - Defense World

Dec 22, 2024
pulisher
Dec 17, 2024

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Recommendation of “Hold” by Brokerages - Defense World

Dec 17, 2024
pulisher
Dec 17, 2024

Longboard Pharmaceuticals' SWOT analysis: bexicaserin potential drives stock outlook - Investing.com

Dec 17, 2024
pulisher
Dec 16, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.84 Million Stake in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - Defense World

Dec 16, 2024
pulisher
Dec 14, 2024

Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal - MSN

Dec 14, 2024
pulisher
Dec 09, 2024

Longboard Pharmaceuticals' SWOT analysis: bexicaserin stock poised for growth - Investing.com

Dec 09, 2024
pulisher
Dec 08, 2024

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Shares Sold by Quantbot Technologies LP - MarketBeat

Dec 08, 2024
pulisher
Dec 06, 2024

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc.LBPH - The Eastern Progress Online

Dec 06, 2024
pulisher
Dec 06, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INSI, LBPH, NBR on Behalf of Shareholders - The Eastern Progress Online

Dec 06, 2024
pulisher
Dec 05, 2024

Readystate Asset Management LP Makes New Investment in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

Lundbeck to present data at epilepsy congress - Marketscreener.com

Dec 05, 2024
pulisher
Dec 04, 2024

Parkman Healthcare Partners LLC Sells 202,906 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat

Dec 04, 2024
pulisher
Dec 04, 2024

Fmr LLC Has $144.99 Million Stock Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat

Dec 04, 2024
pulisher
Dec 03, 2024

Lundbeck acquires all outstanding shares of Longboard Pharma - MSN

Dec 03, 2024
pulisher
Dec 02, 2024

Longboard Pharmaceuticals concludes merger with H. Lundbeck A/S By Investing.com - Investing.com Australia

Dec 02, 2024
pulisher
Dec 02, 2024

Longboard Pharmaceuticals concludes merger with H. Lundbeck A/S - Investing.com

Dec 02, 2024
pulisher
Dec 02, 2024

Lundbeck completes billion dollar acquisition of Longboard Pharmaceuticals - Marketscreener.com

Dec 02, 2024
pulisher
Nov 30, 2024

Victory Capital Management Inc. Invests $526,000 in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat

Nov 30, 2024
pulisher
Nov 29, 2024

Langkawi Corporation completed the acquisition of Longboard Pharmaceuticals, Inc.. - Marketscreener.com

Nov 29, 2024
pulisher
Nov 28, 2024

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Shares Purchased by Ally Bridge Group NY LLC - MarketBeat

Nov 28, 2024
pulisher
Nov 28, 2024

Lundbeck's acquisition conditions for Longboard have been met, closing the deal on December 2 - Marketscreener.com

Nov 28, 2024
pulisher
Nov 28, 2024

Longboard Pharmaceuticals stock soars to all-time high of $59.96 By Investing.com - Investing.com Nigeria

Nov 28, 2024
pulisher
Nov 27, 2024

Longboard Pharmaceuticals stock soars to all-time high of $59.96 - Investing.com

Nov 27, 2024
pulisher
Nov 27, 2024

Bright Minds Buosciences Surges 5,900% Last Week. Attention Turning To Cybin ($CYBN) Rallying 23% On Upcoming... - Daily Scanner

Nov 27, 2024
pulisher
Nov 26, 2024

Bright Minds initiated at outperform by Baird, Longboard takeover cited (NASDAQ:DRUG) - Seeking Alpha

Nov 26, 2024
pulisher
Nov 24, 2024

KBC Group NV Acquires New Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - Defense World

Nov 24, 2024
pulisher
Nov 22, 2024

Jennison Associates LLC Sells 34,440 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat

Nov 22, 2024
pulisher
Nov 22, 2024

Brokerages Set Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Price Target at $59.56 - MarketBeat

Nov 22, 2024
pulisher
Nov 20, 2024

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of MARX, BRKH, MNTX and LPBH - GlobeNewswire Inc.

Nov 20, 2024
pulisher
Nov 20, 2024

Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage - MSN

Nov 20, 2024
pulisher
Nov 18, 2024

299,156 Shares in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Bought by Braun Stacey Associates Inc. - MarketBeat

Nov 18, 2024
pulisher
Nov 13, 2024

Longboard Pharmaceuticals Initiates Phase 3 DEEp Ocean Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies - Marketscreener.com

Nov 13, 2024
pulisher
Nov 12, 2024

LBPHLongboard Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs) - Business Wire

Nov 12, 2024
pulisher
Nov 12, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates B, LBPH, ZUO on Behalf of Shareholders - PR Newswire

Nov 12, 2024
pulisher
Nov 08, 2024

Longboard Pharmaceuticals Advances Neurological Treatments - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - BioSpace

Nov 07, 2024
pulisher
Nov 07, 2024

Longboard Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

FMR LLC Reduces Stake in Longboard Pharmaceuticals Inc - GuruFocus.com

Nov 07, 2024
pulisher
Nov 06, 2024

How the (LBPH) price action is used to our Advantage - Stock Traders Daily

Nov 06, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Longboard Pharmace - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

Longboard Pharmaceuticals granted Orphan Drug Designation for bexicaserin - TipRanks

Nov 04, 2024
pulisher
Nov 03, 2024

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Position Increased by Emerald Advisers LLC - MarketBeat

Nov 03, 2024
pulisher
Nov 03, 2024

Longboard Pharmaceuticals (NASDAQ:LBPH) Hits New 1-Year High – Here’s What Happened - Defense World

Nov 03, 2024
pulisher
Nov 01, 2024

Longboard Pharmaceuticals stock soars to all-time high of $59.95 By Investing.com - Investing.com South Africa

Nov 01, 2024
pulisher
Nov 01, 2024

Longboard Pharmaceuticals (NASDAQ:LBPH) Reaches New 52-Week HighShould You Buy? - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

500: Something went wrong - Investing.com

Nov 01, 2024
pulisher
Oct 31, 2024

Longboard Pharmaceuticals Inc options imply 0.8% move in share price post-earnings - TipRanks

Oct 31, 2024
pulisher
Oct 31, 2024

LONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc.LBPH - Business Wire

Oct 31, 2024

Finanzdaten der Longboard Pharmaceuticals Inc-Aktie (LBPH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$69.84
price up icon 1.45%
$18.67
price up icon 4.48%
$39.59
price up icon 0.51%
$363.65
price up icon 1.13%
$177.70
price up icon 0.68%
$113.51
price up icon 0.38%
Kapitalisierung:     |  Volumen (24h):